Ferramentas Pessoais
Você está aqui: Entrada News BIAL’s antiepileptic approved in the U.S.

BIAL’s antiepileptic approved in the U.S.

Portuguese medicine available for U.S. patients in 2014. Antiepileptic of BIAL’s research and development is already marketed in 18 European countries.

 

BIAL’s antiepileptic, the first medicine with a Portuguese patent, has just been approved by the regulator of the pharmaceutical market in the U.S., Food and Drug Administration (FDA), for the commercialization in the United States.

Read the full text here.

 

(BIAL, 11 November 2013)